has function has role immunizes against disease immunizes recipient test in lab animal model melanoma Mus musculus Homo sapiens melanoma vaccine therapeutic vaccine function peptide vaccine vaccine in clinical trial role peptide vaccine role NA17.A2 peptide vaccine A peptide cancer vaccine comprised of human leukocyte antigen HLA-A2-restricted peptide derived from a metastatic melanoma cell line of patient NA17, with potential immunomodulating and antineoplastic activity. NA17. A2 peptide vaccine may stimulate a cytotoxic T lymphocyte (CTL) response against tumors that express this antigen, which may result in a reduction in tumor size. This NA17 specific antigen, encoded by an intron sequence of N-acetylglucosaminyltransferase V (GnT-V) gene, is expressed in about 50% of melanomas. Gene name: MAGEA3 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5323 PMID:16133111 5323 4102 Gene name: MLANA Gene name: PMEL Jimmy Guo 107653060 2315 cancer vaccine Virginia He Jie Zheng 6490 NCT: https://clinicaltrials.gov/ct2/show/NCT01307618 NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C2680 https://github.com/vaccineontology/VO/issues/49 Gene name: IL12 Oliver He therapeutic cancer vaccine